These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10191287)

  • 1. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
    Marcoux C; Tremblay M; Nakajima K; Davignon J; Cohn JS
    J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects.
    Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
    Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS
    J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
    Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS
    Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state.
    Marcoux C; Hopkins PN; Wang T; Leary ET; Nakajima K; Davignon J; Cohn JS
    J Lipid Res; 2000 Sep; 41(9):1428-36. PubMed ID: 10974050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H; Perlov D; Khoo C; Sacks FM
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC.
    Okazaki M; Usui S; Tada N; Nakano T; Nakajima K
    Clin Chim Acta; 2000 Jun; 296(1-2):135-49. PubMed ID: 10807977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
    Evans AJ; Huff MW; Wolfe BM
    J Lipid Res; 1989 Nov; 30(11):1691-701. PubMed ID: 2614271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
    Khoo C; Campos H; Judge H; Sacks FM
    J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
    Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED; Le NA; Li X; Martinson D; Brown WV
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
    Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P
    J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 20. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.
    Devaraj S; Vega G; Lange R; Grundy SM; Jialal I
    Am J Med; 1998 May; 104(5):445-50. PubMed ID: 9626027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.